INNOVATE Corp (VATE)
NYSE:VATE
Want to see VATE full AI Analyst Report?
Earnings Data
Report Date
Aug 12, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
―Last Year’s EPS
-1.67Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call reflects a predominantly positive operational story driven by a strong Infrastructure / DBMG performance that delivered outsized revenue (up 33% consolidated) and adjusted EBITDA improvement. Significant regulatory and clinical milestones at MediBeacon and international growth at R2 are constructive. However, meaningful challenges remain in smaller but important areas: Life Sciences revenues fell sharply (-48.4%), R2 is seeking external capital, Spectrum experienced advertising weakness and cancellations, DBMG saw ~140 bps gross margin compression, and consolidated debt increased due to PIK interest. Overall, the positive momentum in the company’s largest revenue driver and improved overall profitability outweighs the segment‑level headwinds, but capital structure and segment weaknesses warrant continued attention.Company Guidance
Consolidated Revenue Growth
Consolidated revenues of $364.8 million in Q1 2026, an increase of 33% versus $274.2 million in Q1 2025, driven primarily by Infrastructure.
Adjusted EBITDA Improvement
Total adjusted EBITDA of $19.7 million in Q1 2026, up from $7.2 million in the prior year period, reflecting operational improvement across segments (primarily Infrastructure and Life Sciences).
Infrastructure Segment Strength (DBMG)
Infrastructure revenue of $357.9 million, up 35.1% from $264.9 million a year ago; Infrastructure adjusted EBITDA rose to $23.0 million from $16.7 million. Adjusted backlog held at $1.8 billion with reported backlog at $1.6 billion, and DBMG exited the quarter with strong momentum and near‑record backlog levels.
Net Loss Narrowed
Net loss attributable to common stockholders decreased to $17.2 million, or $1.29 per diluted share, versus $24.8 million, or $1.89 per diluted share, in the prior year period, indicating improved profitability trends.
Life Sciences Regulatory and Clinical Milestones (MediBeacon)
MediBeacon completed a notified body quality systems audit with no reservations, received CE mark for TGFR monitor and reusable sensor, secured multiple IDE approvals (ocular angiography, TGFR wireless sensor, renal functional reserve study), and advanced clinical enrollment—positioning the business for broader approvals in major markets.
R2 Commercial Momentum and International Growth
R2 reported worldwide revenue of $1.6 million with total demand of $2.2 million; backlog of ~160 systems (~$2 million). International gross system sales increased 58.6% YoY, and a new distributor in South Korea targets an estimated $2 million opportunity.
Stronger Liquidity Position
Consolidated cash and cash equivalents increased to $134.6 million as of March 31, 2026, up from $112.1 million at December 31, 2025, providing additional near‑term liquidity.
VATE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
VATE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 14, 2026 | $11.68 | $10.66 | -8.73% |
Mar 26, 2026 | $4.03 | $4.59 | +13.90% |
Nov 12, 2025 | $5.47 | $5.60 | +2.38% |
Aug 05, 2025 | $5.76 | $5.68 | -1.39% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does INNOVATE Corp (VATE) report earnings?
INNOVATE Corp (VATE) is schdueled to report earning on Aug 12, 2026, After Close (Confirmed).
What is INNOVATE Corp (VATE) earnings time?
INNOVATE Corp (VATE) earnings time is at Aug 12, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is VATE EPS forecast?
Currently, no data Available